Cathecol-O-methyltransferase inhibitors: another possibly useful pharmacological tool for treating Parkinson's disease in pregnancy?

J Obstet Gynaecol. 2017 Apr;37(3):381-382. doi: 10.1080/01443615.2016.1250735. Epub 2016 Dec 26.

Authors

Stefano Basile¹, Sara Pinelli¹, Silvia Garibaldi¹, Claudia Altamura², Marco Calcagno³, Maria Giovanna Salerno¹

Affiliations

¹ a Maternal and Childlike Department, Division of Obstetrics and Gynecology 2 , Pisa University Hospital , Pisa , Italy.
² b Neurology Department , Università Campus Bio-Medico di Roma , Rome , Italy.
³ c Obstetrics and Gynecology Department , S. Spirito Hospital , Rome , Italy.

PMID: 28013564
DOI: 10.1080/01443615.2016.1250735

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Carbidopa / therapeutic use
Catechol O-Methyltransferase
Catechol O-Methyltransferase Inhibitors / adverse effects
Catechol O-Methyltransferase Inhibitors / therapeutic use*
Catechols / adverse effects
Catechols / therapeutic use*
Cesarean Section
Female
Gestational Age
Humans
Infant, Newborn
Levodopa / therapeutic use
Nitriles / adverse effects
Nitriles / therapeutic use*
Parkinson Disease / complications*
Parkinson Disease / drug therapy*
Pregnancy
Pregnancy Complications / drug therapy*
Pregnancy Outcome*

Substances

Catechol O-Methyltransferase Inhibitors
Catechols
Nitriles
Levodopa
entacapone
Catechol O-Methyltransferase
Carbidopa